专题:Hormonal Regulation and Hypertension

This cluster of papers focuses on the management, diagnosis, and treatment of Primary Aldosteronism, a condition characterized by the overproduction of aldosterone by the adrenal glands. The research covers topics such as case detection, cardiovascular events, glucocorticoid and mineralocorticoid receptor actions, hypertension, and the use of spironolactone therapy. Additionally, it explores the association with metabolic syndrome and renal injury.
最新文献
Aldosterone and Impaired Nocturnal Blood Pressure Decline in Primary Aldosteronism

article Full Text OpenAlex

Finerenone in Type 1 Diabetes and Chronic Kidney Disease

article Full Text OpenAlex

7-T Potassium ( 39 K) MRI to Assess Muscle K + Depletion in Primary Aldosteronism

article Full Text OpenAlex

Systolic Blood Pressure Targets in Patients With Hypertension With and Without Cardiovascular Disease: A Pooled Analysis of 4 Randomized Clinical Trials

article Full Text OpenAlex

Mollisonia is probably not an arachnid

article Full Text OpenAlex

Emerging Medical Therapies for Primary Aldosteronism

article Full Text OpenAlex

Seated Saline Suppression Test for Lateralizing Primary Aldosteronism

article Full Text OpenAlex

Clinical features, investigation, and management of Addison's disease

article Full Text OpenAlex

Direct measurement of free glucocorticoids in small volumes of mouse and rat serum using ultrafiltration and liquid chromatography-tandem mass spectrometry

article Full Text OpenAlex

Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Multicenter Prospective Study

article Full Text OpenAlex

近5年高被引文献
A non-canonical vitamin K cycle is a potent ferroptosis suppressor

article Full Text OpenAlex 635 FWCI61.3188

European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors

article Full Text OpenAlex 582 FWCI183.4401

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

article Full Text OpenAlex 561 FWCI206.4267

Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets

review Full Text OpenAlex 329 FWCI53.9084

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension

article Full Text OpenAlex 322 FWCI41.441

Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease

review Full Text OpenAlex 319 FWCI71.313

Overview of the 2022 WHO Classification of Adrenal Cortical Tumors

review Full Text OpenAlex 286 FWCI57.9866

Sex Differences in the Prevalence, Outcomes and Management of Hypertension

review Full Text OpenAlex 273 FWCI41.5329

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

article Full Text OpenAlex 256 FWCI52.2234

Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

review Full Text OpenAlex 248 FWCI50.9865